Evotec SE (EVO) Research & Development (2009 - 2025)

Evotec SE (EVO) reported Research & Development of $43.7 million for Q4 2025, down 19.66% on a YoY basis from $54.4 million in Q4 2024, and up 429065.53% sequentially from -$10186.0 in Q3 2025.

Evotec SE (EVO) Research & Development (2009 - 2025) Analysis & Trends

Evotec SE (EVO) has 9 years of Research & Development data on file, last reported at $43.7 million in Q4 2025.

  • For the quarter ending Q4 2025, Research & Development fell 19.66% year-over-year to $43.7 million; the trailing twelve-month figure through Dec 2025 stood at $98.1 million (down 23.5% YoY), and the FY2025 full-year result was $43.7 million, down 19.66% from the prior year.
  • Research & Development improved to $43.7 million in Q4 2025, from -$10186.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $82.5 million in Q4 2021 to a low of -$22267.1 in Q1 2021.
  • A 5-year average of $22.2 million and a median of $18634.9 in 2022 frame the typical range for Research & Development.
  • Across the five-year window, Research & Development plunged 168.44% in 2024 and gained 21.89% in 2025, its largest moves.
  • Tracing EVO's Research & Development over 5 years: stood at $82.5 million in 2021, then declined by 5.33% to $78.1 million in 2022, then decreased by 5.57% to $73.8 million in 2023, then dropped by 26.29% to $54.4 million in 2024, then retreated by 19.66% to $43.7 million in 2025.
  • Business Quant data shows EVO's Research & Development at $43.7 million in Q4 2025, -$10186.0 in Q3 2025, and $54.4 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 696.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 180.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 7.37 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 138.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 248.60 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 296.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 97.00 Mn
10 Evotec SE 351.60 Mn 351.08 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 43.69 Mn
Sep 30, 2025 -10,185.98
Dec 31, 2024 54.39 Mn
Sep 30, 2024 -13,040.26
Dec 31, 2023 73.79 Mn
Sep 30, 2023 19,053.60
Jun 30, 2023 -20,129.86
Dec 31, 2022 78.14 Mn
Sep 30, 2022 18,634.93
Jun 30, 2022 -19,980.64
Mar 31, 2022 -20,328.90
Dec 31, 2021 82.53 Mn
Sep 30, 2021 21,271.98
Jun 30, 2021 -20,441.30
Mar 31, 2021 -22,267.12
Dec 31, 2020 76.19 Mn
Sep 30, 2020 19,017.47
Dec 31, 2019 64.67 Mn
Sep 30, 2010 1,611.51
Jun 30, 2010 1,520.88